AZD-5991

DB14792InvestigationalSmall molecule

AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.).

Chemical structure of AZD-5991
Formula / weight
C35H34ClN5O3S2 · 672.26 g/mol (avg)
Code names
AZD-5991

Resolves to

Compound
UNIIE3T5XXY9HXCAS2143010-83-5
Structure
InChIKeyKBQCEQAXHPIRTF-UHFFFAOYSA-NSMILESCN1N=C2CSCC3=NN(C)C(CSC4=CC5=C(C=CC=C5)C(OCCCC5=C(N(C)C6=C5C=CC(Cl)=C6C2=C1C)C(O)=O)=C4)=C3
Targets
Q07820MCL1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with AZD-5991, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In